Hemoglobin	B-protein
switching	O
in	O
humans	O
is	O
accompanied	O
by	O
changes	O
in	O
the	O
ratio	O
of	O
the	O
transcription	B-protein
factors	I-protein
,	O
GATA-1	B-protein
and	O
SP1	B-protein
.	O

BACKGROUND	O
:	O
Understanding	O
the	O
mechanism	O
of	O
developmental	O
regulation	O
of	O
hemoglobin	B-protein
switching	O
has	O
scientific	O
as	O
well	O
as	O
clinical	O
relevance	O
because	O
of	O
the	O
influence	O
of	O
fetal	O
hemoglobin	B-protein
(	O
HbF	B-protein
)	O
production	O
in	O
adulthood	O
on	O
the	O
clinical	O
manifestation	O
of	O
thalassemia	O
and	O
sickle	O
cell	O
anemia	O
.	O

We	O
have	O
previously	O
found	O
that	O
the	O
normal	O
developmental	O
patterns	O
of	O
globin	B-DNA
gene	I-DNA
expression	O
are	O
recapitulated	O
in	O
an	O
experimental	O
system	O
of	O
primary	B-cell_line
cultures	I-cell_line
that	O
support	O
differentiation	O
of	O
erythroid	B-cell_type
progenitors	I-cell_type
.	O

We	O
further	O
found	O
that	O
high	O
activities	O
of	O
the	O
transcriptional	B-protein
activators	I-protein
,	O
GATA-1	B-protein
and	O
SP1	B-protein
,	O
are	O
associated	O
with	O
normal	O
adult	O
erythroid	O
differentiation	O
.	O

MATERIALS	O
AND	O
METHODS	O
:	O
In	O
the	O
present	O
work	O
,	O
we	O
have	O
studied	O
,	O
the	O
activities	O
of	O
GATA-1	B-protein
and	O
SP1	B-protein
during	O
differentiation	O
of	O
cultured	O
erythroid	B-cell_type
progenitors	I-cell_type
derived	O
from	O
cord	O
blood	O
and	O
from	O
fetal	O
livers	O
,	O
as	O
well	O
as	O
from	O
beta	O
zero-thalassemia	O
patients	O
.	O

RESULTS	O
:	O
The	O
results	O
showed	O
high	O
GATA-1	B-protein
binding	O
activity	O
and	O
very	O
low	O
SP1	B-protein
activity	O
in	O
the	O
fetal	B-cell_line
liver	I-cell_line
cultures	I-cell_line
.	O

This	O
pattern	O
was	O
in	O
contrast	O
to	O
cultures	O
derived	O
from	O
normal	O
adult	O
peripheral	O
blood	O
,	O
in	O
which	O
both	O
GATA-1	B-protein
and	O
SP1	B-protein
activities	O
were	O
high	O
.	O

Cord	O
blood	O
cultures	O
showed	O
an	O
additive	O
combination	O
of	O
``	O
adult	O
''	O
and	O
``	O
fetal	O
''	O
patterns	O
.	O

The	O
progenitors	O
derived	O
from	O
a	O
beta	O
zero-thalassemia	O
patient	O
with	O
high	O
HbF	B-protein
production	O
showed	O
``	O
fetal	O
''	O
pattern	O
.	O

On	O
the	O
other	O
hand	O
,	O
in	O
cultures	O
of	O
2	O
beta	O
zero-thalassemia	O
patients	O
without	O
high	O
HbF	B-protein
,	O
``	O
adult	O
''	O
pattern	O
was	O
observed	O
.	O

CONCLUSIONS	O
:	O
In	O
the	O
present	O
work	O
,	O
we	O
show	O
that	O
human	B-cell_type
fetal	I-cell_type
and	I-cell_type
adult	I-cell_type
erythroid	I-cell_type
progenitors	I-cell_type
are	O
distinct	O
in	O
their	O
transcription	B-protein
factors	I-protein
,	O
and	O
that	O
the	O
commitment	O
to	O
fetal	O
or	O
adult	O
program	O
occurs	O
at	O
a	O
very	O
early	O
differentiation	O
stage	O
.	O

Our	O
studies	O
also	O
demonstrate	O
that	O
under	O
anemic	O
stress	O
,	O
recruitment	O
of	O
fetal	B-cell_type
progenitors	I-cell_type
may	O
occur	O
in	O
adulthood	O
.	O

Hemoglobin	NULL
Switching	NULL
in	NULL
Humans	NULL
Is	NULL
Accompanied	NULL
by	NULL
Changes	NULL
in	NULL
the	NULL
Ratio	NULL
of	NULL
the	NULL
Transcription	NULL
Factors	NULL
,	NULL
GATA-1	NULL
and	NULL
SPI	NULL
E.	NULL
Rena	NULL
Bacon	NULL
,	NULL
*	NULL
'	NULL
Nava	NULL
Dalyot	NULL
,	NULL
*	NULL
Dvora	NULL
Filon	NULL
,	NULL
*	NULL
Letizia	NULL
Schreiber	NULL
,	NULL
!	NULL

Eliezer	NULL
A.	NULL
Rachmilewitz	NULL
,	NULL
*	NULL
and	NULL
Ariella	NULL
Oppenheim*	NULL
Departments	NULL
of	NULL
*Hematology	NULL
and	NULL
tPathology	NULL
,	NULL
Hebrew	NULL
University-Hadassah	NULL
Medical	NULL
School	NULL
and	NULL
Hadassah	NULL
University	NULL
Hospital	NULL
,	NULL
Jerusalem	NULL
,	NULL
Israel	NULL
ABSTRACT	NULL
Background	NULL
:	NULL
Understanding	NULL
the	NULL
mechanism	NULL
of	NULL
developmental	NULL
regulation	NULL
of	NULL
hemoglobin	NULL
switching	NULL
has	NULL
scientific	NULL
as	NULL
well	NULL
as	NULL
clinical	NULL
relevance	NULL
because	NULL
of	NULL
the	NULL
influence	NULL
of	NULL
fetal	NULL
hemoglobin	NULL
(	NULL
HbF	NULL
)	NULL
production	NULL
in	NULL
adulthood	NULL
on	NULL
the	NULL
clinical	NULL
manifestation	NULL
of	NULL
thalassemia	NULL
and	NULL
sickle	NULL
cell	NULL
anemia	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
found	NULL
that	NULL
the	NULL
normal	NULL
developmental	NULL
patterns	NULL
of	NULL
globin	NULL
gene	NULL
expression	NULL
are	NULL
recapitulated	NULL
in	NULL
an	NULL
experimental	NULL
system	NULL
of	NULL
primary	NULL
cultures	NULL
that	NULL
support	NULL
differentiation	NULL
of	NULL
erythroid	NULL
progenitors	NULL
.	NULL

We	NULL
further	NULL
found	NULL
that	NULL
high	NULL
activities	NULL
of	NULL
the	NULL
transcriptional	NULL
activators	NULL
,	NULL
GATA-I	NULL
and	NULL
SPI	NULL
,	NULL
are	NULL
associated	NULL
with	NULL
normal	NULL
adult	NULL
erythroid	NULL
differentiation	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
:	NULL
In	NULL
the	NULL
present	NULL
work	NULL
,	NULL
we	NULL
have	NULL
studied	NULL
the	NULL
activities	NULL
of	NULL
GATA-1	NULL
and	NULL
SP1	NULL
during	NULL
differentiation	NULL
of	NULL
cultured	NULL
erythroid	NULL
progenitors	NULL
derived	NULL
from	NULL
cord	NULL
blood	NULL
and	NULL
from	NULL
fetal	NULL
livers	NULL
,	NULL
as	NULL
well	NULL
as	NULL
from	NULL
B°-thalassemia	NULL
patients	NULL
.	NULL

Results	NULL
:	NULL
The	NULL
results	NULL
showed	NULL
high	NULL
GATA-1	NULL
binding	NULL
ac	NULL
tivity	NULL
and	NULL
very	NULL
low	NULL
SP1	NULL
activity	NULL
in	NULL
the	NULL
fetal	NULL
liver	NULL
cultures	NULL
.	NULL

This	NULL
pattem	NULL
was	NULL
in	NULL
contrast	NULL
to	NULL
cultures	NULL
derived	NULL
from	NULL
normal	NULL
adult	NULL
peripheral	NULL
blood	NULL
,	NULL
in	NULL
which	NULL
both	NULL
GATA-1	NULL
and	NULL
SPI	NULL
activities	NULL
were	NULL
high	NULL
.	NULL

Cord	NULL
blood	NULL
cultures	NULL
showed	NULL
an	NULL
additive	NULL
combination	NULL
of	NULL
``	NULL
adult	NULL
``	NULL
and	NULL
``	NULL
fetal	NULL
``	NULL
patterns	NULL
.	NULL

The	NULL
progenitors	NULL
derived	NULL
from	NULL
a	NULL
B°-thalassemia	NULL
patient	NULL
with	NULL
high	NULL
HbF	NULL
production	NULL
showed	NULL
``	NULL
fetal	NULL
``	NULL
pattern	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
in	NULL
cultures	NULL
of	NULL
2	NULL
B°-thalassemia	NULL
patients	NULL
without	NULL
high	NULL
HbF	NULL
,	NULL
``	NULL
adult	NULL
``	NULL
pattem	NULL
was	NULL
ob-served	NULL
.	NULL

Conclusions	NULL
:	NULL
In	NULL
the	NULL
present	NULL
work	NULL
,	NULL
we	NULL
show	NULL
that	NULL
human	NULL
fetal	NULL
and	NULL
adult	NULL
erythroid	NULL
progenitors	NULL
are	NULL
distinct	NULL
in	NULL
their	NULL
transcription	NULL
factors	NULL
,	NULL
and	NULL
that	NULL
the	NULL
commitment	NULL
to	NULL
fetal	NULL
or	NULL
adult	NULL
program	NULL
occurs	NULL
at	NULL
a	NULL
very	NULL
early	NULL
differentiation	NULL
stage	NULL
.	NULL

Our	NULL
studies	NULL
also	NULL
demonstrate	NULL
that	NULL
under	NULL
anemic	NULL
stress	NULL
,	NULL
recruitment	NULL
of	NULL
fetal	NULL
progenitors	NULL
may	NULL
occur	NULL
in	NULL
adulthood	NULL
.	NULL

INTRODUCTION	NULL
Elucidation	NULL
of	NULL
the	NULL
mechanism	NULL
underlying	NULL
developmental	NULL
regulation	NULL
of	NULL
hemoglobin	NULL
switching	NULL
has	NULL
important	NULL
medical	NULL
implications	NULL
.	NULL

For	NULL
exam-ple	NULL
,	NULL
elevated	NULL
fetal	NULL
hemoglobin	NULL
(	NULL
HbF	NULL
)	NULL
(	NULL
«	NULL
2y2	NULL
)	NULL
production	NULL
in	NULL
adult	NULL
patients	NULL
with	NULL
sickle	NULL
cell	NULL
anemia	NULL
or	NULL
B-thalassemia	NULL
ameliorates	NULL
the	NULL
disease	NULL
symp-	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
:	NULL
Ariella	NULL
Oppenheim	NULL
,	NULL
Department	NULL
of	NULL
Hematology	NULL
,	NULL
Hebrew	NULL
Univer-sity-Hadassah	NULL
Medical	NULL
School	NULL
,	NULL
Jerusalem	NULL
,	NULL
Israel	NULL
91120	NULL
.	NULL

'On	NULL
Sabbatical	NULL
leave	NULL
from	NULL
Ramapo	NULL
College	NULL
of	NULL
New	NULL
Jersey	NULL
,	NULL
Mahwah	NULL
,	NULL
NJ	NULL
07430-1680	NULL
.	NULL

Copyright	NULL
©	NULL
1995	NULL
,	NULL
Molecular	NULL
Medicine	NULL
,	NULL
1076-1551/95/	NULL
$	NULL
10.50/0	NULL
Molecular	NULL
Medicine	NULL
,	NULL
Volume	NULL
1	NULL
,	NULL
Number	NULL
3	NULL
,	NULL
March	NULL
1995	NULL
297-305	NULL
toms	NULL
,	NULL
as	NULL
the	NULL
y-globin	NULL
chains	NULL
may	NULL
compensate	NULL
for	NULL
the	NULL
reduction	NULL
in	NULL
B-globin	NULL
chains	NULL
.	NULL

In	NULL
some	NULL
individuals	NULL
this	NULL
occurs	NULL
due	NULL
to	NULL
y-globin	NULL
promoter	NULL
mutations	NULL
or	NULL
to	NULL
deletions	NULL
in	NULL
the	NULL
B-globin	NULL
gene	NULL
cluster	NULL
.	NULL

In	NULL
others	NULL
,	NULL
the	NULL
mechanism	NULL
is	NULL
not	NULL
understood	NULL
.	NULL

In	NULL
spite	NULL
of	NULL
intensive	NULL
research	NULL
,	NULL
this	NULL
mechanism	NULL
has	NULL
not	NULL
been	NULL
clarified	NULL
,	NULL
partly	NULL
because	NULL
of	NULL
the	NULL
unavailability	NULL
of	NULL
an	NULL
adequate	NULL
animal	NULL
model	NULL
,	NULL
since	NULL
the	NULL
switch	NULL
mechanism	NULL
varies	NULL
among	NULL
different	NULL
mammals	NULL
.	NULL

It	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
normal	NULL
adult	NULL
erythroid	NULL
cells	NULL
go	NULL
through	NULL
a	NULL
``	NULL
fetal	NULL
``	NULL
stage	NULL
during	NULL
differentiation	NULL
before	NULL
maturing	NULL
into	NULL
cells	NULL
producing	NULL
adult	NULL
hemoglobin	NULL
(	NULL
«	NULL
2B2	NULL
)	NULL
(	NULL
1	NULL
)	NULL
.	NULL

The	NULL
297	NULL
298	NULL
Molecular	NULL
Medicine	NULL
,	NULL
Volume	NULL
1	NULL
,	NULL
Number	NULL
3	NULL
,	NULL
March	NULL
1995	NULL
clonal	NULL
model	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
invokes	NULL
distinct	NULL
progenitors	NULL
and	NULL
separate	NULL
pathways	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Our	NULL
previous	NULL
studies	NULL
demonstrated	NULL
that	NULL
adult	NULL
and	NULL
neonatal	NULL
patterns	NULL
of	NULL
globin	NULL
gene	NULL
expression	NULL
are	NULL
recapitulated	NULL
in	NULL
liquid	NULL
cultures	NULL
that	NULL
support	NULL
proliferation	NULL
and	NULL
differentiation	NULL
of	NULL
erythroid	NULL
progenitors	NULL
(	NULL
3	NULL
)	NULL
.	NULL

The	NULL
cultures	NULL
are	NULL
grown	NULL
in	NULL
two	NULL
phases	NULL
:	NULL
first	NULL
the	NULL
early	NULL
progenitors	NULL
,	NULL
burst	NULL
forming	NULL
units	NULL
,	NULL
erythroid	NULL
,	NULL
(	NULL
BFUe	NULL
)	NULL
,	NULL
proliferate	NULL
and	NULL
differentiate	NULL
into	NULL
colony	NULL
forming	NULL
units	NULL
,	NULL
erythroid	NULL
(	NULL
CFUe	NULL
)	NULL
.	NULL

Further	NULL
differentiation	NULL
and	NULL
maturation	NULL
,	NULL
including	NULL
globin	NULL
gene	NULL
expression	NULL
and	NULL
hemoglobin	NULL
biosynthesis	NULL
,	NULL
is	NULL
erythropoietin	NULL
(	NULL
EPO	NULL
)	NULL
dependent	NULL
(	NULL
4	NULL
)	NULL
.	NULL

In	NULL
our	NULL
experiments	NULL
(	NULL
3	NULL
)	NULL
,	NULL
cultured	NULL
adult	NULL
progenitors	NULL
,	NULL
from	NULL
peripheral	NULL
blood	NULL
,	NULL
gave	NULL
rise	NULL
primarily	NULL
to	NULL
the	NULL
B-	NULL
and	NULL
a-globin	NULL
expressing	NULL
cells	NULL
,	NULL
while	NULL
progenitors	NULL
of	NULL
neonate	NULL
cord	NULL
blood	NULL
(	NULL
CBL	NULL
)	NULL
differentiated	NULL
into	NULL
cells	NULL
that	NULL
also	NULL
synthesized	NULL
high	NULL
levels	NULL
of	NULL
y-globin	NULL
mRNA	NULL
.	NULL

Those	NULL
experiments	NULL
suggested	NULL
that	NULL
the	NULL
fetal	NULL
progenitors	NULL
are	NULL
distinct	NULL
from	NULL
adult	NULL
progenitors	NULL
and	NULL
that	NULL
CBL	NULL
contains	NULL
a	NULL
mixed	NULL
population	NULL
of	NULL
both	NULL
.	NULL

The	NULL
peak	NULL
of	NULL
y-globin	NULL
gene	NULL
expression	NULL
usually	NULL
preceded	NULL
that	NULL
of	NULL
B	NULL
,	NULL
implying	NULL
that	NULL
fetal	NULL
progenitors	NULL
tend	NULL
to	NULL
differentiate	NULL
faster	NULL
than	NULL
the	NULL
adult	NULL
ones	NULL
.	NULL

We	NULL
further	NULL
found	NULL
that	NULL
the	NULL
appearance	NULL
of	NULL
globin	NULL
mRNA	NULL
in	NULL
adult	NULL
cultures	NULL
was	NULL
preceded	NULL
by	NULL
a	NULL
burst	NULL
in	NULL
the	NULL
level	NULL
of	NULL
GATA-1	NULL
,	NULL
which	NULL
was	NULL
triggered	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
EPO	NULL
(	NULL
5	NULL
)	NULL
.	NULL

GATA-1	NULL
is	NULL
a	NULL
major	NULL
transcriptional	NULL
activator	NULL
of	NULL
erythroid	NULL
differentiation	NULL
(	NULL
6,7	NULL
)	NULL
,	NULL
regulating	NULL
a	NULL
number	NULL
of	NULL
erythroid	NULL
specific	NULL
genes	NULL
,	NULL
including	NULL
globin	NULL
(	NULL
8	NULL
)	NULL
.	NULL

We	NULL
observed	NULL
a	NULL
parallel	NULL
rise	NULL
in	NULL
the	NULL
level	NULL
of	NULL
the	NULL
ubiquitous	NULL
factor	NULL
,	NULL
SPI	NULL
,	NULL
indicating	NULL
that	NULL
not	NULL
only	NULL
GATA-1	NULL
,	NULL
but	NULL
also	NULL
SP1	NULL
participates	NULL
in	NULL
adult	NULL
erythroid	NULL
maturation	NULL
.	NULL

Additional	NULL
evidence	NULL
for	NULL
the	NULL
role	NULL
of	NULL
SP1	NULL
in	NULL
human	NULL
erythroid	NULL
differentiation	NULL
comes	NULL
from	NULL
other	NULL
studies	NULL
.	NULL

Analysis	NULL
of	NULL
binding	NULL
of	NULL
transcriptional	NULL
factors	NULL
at	NULL
the	NULL
B-globin	NULL
locus	NULL
control	NULL
region	NULL
(	NULL
LCR	NULL
)	NULL
suggested	NULL
that	NULL
the	NULL
combination	NULL
of	NULL
SP1	NULL
and	NULL
GATA-1	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
the	NULL
high	NULL
levels	NULL
of	NULL
globin	NULL
gene	NULL
expression	NULL
(	NULL
9	NULL
)	NULL
.	NULL

It	NULL
was	NULL
also	NULL
found	NULL
that	NULL
GATA-1	NULL
and	NULL
SPI	NULL
interact	NULL
at	NULL
the	NULL
y-globin	NULL
promoter	NULL
.	NULL

Depending	NULL
on	NULL
their	NULL
concentrations	NULL
,	NULL
this	NULL
interaction	NULL
led	NULL
to	NULL
synergistic	NULL
transcriptional	NULL
activation	NULL
or	NULL
to	NULL
interference	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
it	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
the	NULL
levels	NULL
of	NULL
GATA-1	NULL
and	NULL
SP1	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
mechanism	NULL
of	NULL
globin	NULL
switching	NULL
in	NULL
the	NULL
chicken	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Primary	NULL
cells	NULL
of	NULL
the	NULL
primitive	NULL
erythroid	NULL
lineage	NULL
were	NULL
found	NULL
to	NULL
contain	NULL
10-fold	NULL
more	NULL
of	NULL
these	NULL
two	NULL
factors	NULL
than	NULL
did	NULL
cells	NULL
of	NULL
the	NULL
definitive	NULL
erythroid	NULL
lineage	NULL
.	NULL

In	NULL
the	NULL
present	NULL
work	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
activities	NULL
of	NULL
GATA-1	NULL
and	NULL
SP1	NULL
in	NULL
primary	NULL
cultures	NULL
de-	NULL
rived	NULL
from	NULL
CBL	NULL
,	NULL
mid-gestation	NULL
fetal	NULL
livers	NULL
,	NULL
and	NULL
adult	NULL
B-thalassemia	NULL
patients	NULL
with	NULL
high	NULL
and	NULL
low	NULL
HbF	NULL
production	NULL
.	NULL

Our	NULL
results	NULL
indicate	NULL
that	NULL
fetal	NULL
and	NULL
adult	NULL
erythroid	NULL
differentiation	NULL
occurs	NULL
along	NULL
separate	NULL
pathways	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Erythroid	NULL
Cultures	NULL
CBL	NULL
samples	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
Hadassah	NULL
maternity	NULL
ward	NULL
.	NULL

Liver	NULL
tissues	NULL
were	NULL
derived	NULL
from	NULL
fetuses	NULL
aborted	NULL
at	NULL
20	NULL
weeks	NULL
gestational	NULL
age	NULL
(	NULL
be-cause	NULL
of	NULL
a	NULL
nonglobin	NULL
genetic	NULL
defect	NULL
)	NULL
,	NULL
obtained	NULL
from	NULL
the	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
Hebrew	NULL
University	NULL
(	NULL
Jerusalem	NULL
,	NULL
Israel	NULL
)	NULL
.	NULL

Peripheral	NULL
blood	NULL
samples	NULL
of	NULL
B-thalassemia	NULL
patients	NULL
were	NULL
withdrawn	NULL
prior	NULL
to	NULL
transfusions	NULL
.	NULL

All	NULL
samples	NULL
were	NULL
obtained	NULL
according	NULL
to	NULL
the	NULL
Helsinki	NULL
Committee	NULL
guidelines	NULL
.	NULL

The	NULL
liver	NULL
tissues	NULL
were	NULL
finely	NULL
minced	NULL
and	NULL
dispersed	NULL
by	NULL
pipetting	NULL
.	NULL

The	NULL
cultures	NULL
were	NULL
grown	NULL
in	NULL
two	NULL
phases	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
3,4	NULL
)	NULL
.	NULL

The	NULL
dispersed	NULL
liver	NULL
cells	NULL
,	NULL
or	NULL
buffy	NULL
coats	NULL
of	NULL
the	NULL
blood	NULL
samples	NULL
,	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
conditioned	NULL
medium	NULL
from	NULL
human	NULL
bladder	NULL
carcinoma	NULL
cells	NULL
for	NULL
7	NULL
days	NULL
(	NULL
from	NULL
Day	NULL
-7	NULL
to	NULL
Day	NULL
0	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
washed	NULL
and	NULL
recultured	NULL
in	NULL
medium	NULL
supplemented	NULL
with	NULL
1	NULL
U/ml	NULL
recombinant	NULL
EPO	NULL
.	NULL

Microscopic	NULL
slides	NULL
were	NULL
prepared	NULL
by	NULL
cytospin	NULL
,	NULL
following	NULL
lysis	NULL
of	NULL
the	NULL
enucleated	NULL
red	NULL
blood	NULL
cells	NULL
with	NULL
H,0	NULL
,	NULL
and	NULL
stained	NULL
with	NULL
May-Grunwald	NULL
Giemsa	NULL
.	NULL

Hemoglobinized	NULL
cells	NULL
were	NULL
identified	NULL
by	NULL
the	NULL
benzidine	NULL
peroxidase	NULL
reaction	NULL
(	NULL
12	NULL
)	NULL
.	NULL

RNA	NULL
Analyses	NULL
RNA	NULL
was	NULL
purified	NULL
from	NULL
cytoplasmic	NULL
miniextracts	NULL
,	NULL
prepared	NULL
in	NULL
parallel	NULL
to	NULL
nuclear	NULL
extracts	NULL
(	NULL
13,14	NULL
)	NULL
from	NULL
a	NULL
total	NULL
of	NULL
2	NULL
X	NULL
10°	NULL
cells	NULL
.	NULL

Reverse	NULL
transcription	NULL
(	NULL
RT	NULL
)	NULL
was	NULL
performed	NULL
with	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
.	NULL

The	NULL
primers	NULL
for	NULL
PCR	NULL
were	NULL
the	NULL
following	NULL
:	NULL
for	NULL
y-globin	NULL
,	NULL
the	NULL
5	NULL
'	NULL
primer	NULL
was	NULL
ACAAGGCTACTAT	NULL
CACAAGCCT	NULL
(	NULL
exon	NULL
1	NULL
)	NULL
,	NULL
and	NULL
the	NULL
3	NULL
'	NULL
primer	NULL
was	NULL
CTITATGGCATCTCCCAAGGAA	NULL
(	NULL
exon	NULL
2	NULL
)	NULL
;	NULL
for	NULL
fB-globin	NULL
,	NULL
the	NULL
5	NULL
primer	NULL
was	NULL
CACCTITGCCA	NULL
CACTGAGTGA	NULL
(	NULL
exon	NULL
2	NULL
)	NULL
,	NULL
and	NULL
the	NULL
3	NULL
'	NULL
primer	NULL
CCA	NULL
GATGCTCAAGGCCCTTC	NULL
(	NULL
from	NULL
the	NULL
untranslated	NULL
region	NULL
3	NULL
'	NULL
to	NULL
exon	NULL
3	NULL
)	NULL
.	NULL

The	NULL
amplification	NULL
cycle	NULL
was	NULL
92°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
60°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
and	NULL
72°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
repeated	NULL
for	NULL
30	NULL
cycles	NULL
.	NULL

The	NULL
reaction	NULL
products	NULL
were	NULL
visualized	NULL
by	NULL
ethidium	NULL
bromide	NULL
staining	NULL
following	NULL
electrophoresis	NULL
on	NULL
8	NULL
%	NULL
native	NULL
acrylamide	NULL
gels	NULL
.	NULL

The	NULL
PCR	NULL
primers	NULL
for	NULL
the	NULL
GATA-l	NULL
mRNA	NULL
E.	NULL
R.	NULL
Bacon	NULL
et	NULL
al	NULL
.	NULL

:	NULL
Transcription	NULL
Factors	NULL
in	NULL
Hemoglobin	NULL
Switching	NULL
299	NULL
analysis	NULL
were	NULL
GCCCATCTCTACCAAGGCCT	NULL
and	NULL
AGAAGGACACCACCCCTCCT	NULL
,	NULL
derived	NULL
from	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
human	NULL
GATA-1	NULL
mRNA	NULL
,	NULL
producing	NULL
a	NULL
204	NULL
bp	NULL
amplification	NULL
product	NULL
(	NULL
5	NULL
)	NULL
.	NULL

The	NULL
PCR	NULL
primers	NULL
for	NULL
GATA-2	NULL
analysis	NULL
were	NULL
CCCTAAG	NULL
CAGCGCAGCAAGAC	NULL
and	NULL
GATGAGTGGTCGG	NULL
TTCTGGCC	NULL
(	NULL
15	NULL
)	NULL
.	NULL

The	NULL
amplification	NULL
cycle	NULL
for	NULL
both	NULL
GATA-1	NULL
and	NULL
GATA-2	NULL
was	NULL
92°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
62°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
and	NULL
72°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
repeated	NULL
for	NULL
30	NULL
cycles	NULL
.	NULL

Preparation	NULL
of	NULL
Nuclear	NULL
Extracts	NULL
and	NULL
Gel	NULL
Retardation	NULL
Assays	NULL
Nuclear	NULL
miniextracts	NULL
(	NULL
13	NULL
)	NULL
were	NULL
prepared	NULL
from	NULL
a	NULL
total	NULL
of	NULL
2	NULL
X	NULL
10°	NULL
cells	NULL
for	NULL
each	NULL
time-point	NULL
.	NULL

Binding	NULL
activities	NULL
of	NULL
GATA-1	NULL
and	NULL
SP1	NULL
were	NULL
assayed	NULL
by	NULL
the	NULL
gel	NULL
retardation	NULL
assay	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Oligonucleotides	NULL
for	NULL
the	NULL
gel	NULL
retardation	NULL
assay	NULL
were	NULL
the	NULL
following	NULL
:	NULL
for	NULL
GATA-1	NULL
,	NULL
CGGGCAACT	NULL
GATAAGGATTCCCA	NULL
,	NULL
derived	NULL
from	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
mouse	NULL
a-1	NULL
globin	NULL
gene	NULL
(	NULL
16	NULL
)	NULL
;	NULL
and	NULL
for	NULL
SPI	NULL
,	NULL
CTTGGGGGCCCCTCCCCCACACTATCTCAAT	NULL
,	NULL
derived	NULL
from	NULL
the	NULL
human	NULL
y-globin	NULL
gene	NULL
(	NULL
this	NULL
oligonucleotide	NULL
contains	NULL
a	NULL
T	NULL
to	NULL
C	NULL
transition	NULL
at	NULL
position	NULL
-198	NULL
,	NULL
creating	NULL
a	NULL
strong	NULL
SP1	NULL
binding	NULL
site	NULL
)	NULL
(	NULL
17	NULL
)	NULL
.	NULL

The	NULL
specific	NULL
5	NULL
end-labeled	NULL
oligonucleotides	NULL
were	NULL
annealed	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
the	NULL
complementary	NULL
oligonucleotide	NULL
and	NULL
repurified	NULL
by	NULL
poly-acrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
performed	NULL
on	NULL
equal	NULL
amounts	NULL
of	NULL
nuclear	NULL
proteins	NULL
obtained	NULL
from	NULL
1.2	NULL
X	NULL
10°	NULL
cells	NULL
.	NULL

Competition	NULL
experiments	NULL
were	NULL
performed	NULL
by	NULL
adding	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
competitor	NULL
oligonucleotide	NULL
.	NULL

The	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
then	NULL
separated	NULL
on	NULL
5	NULL
%	NULL
native	NULL
polyacryl-amide	NULL
gels	NULL
.	NULL

Intensities	NULL
of	NULL
the	NULL
shifted	NULL
bands	NULL
were	NULL
determined	NULL
by	NULL
phospho-imaging	NULL
of	NULL
the	NULL
gels	NULL
using	NULL
the	NULL
Bio-Imaging	NULL
Analyzer	NULL
,	NULL
BAS1000	NULL
,	NULL
FUJIX	NULL
.	NULL

RESULTS	NULL
GATA-1	NULL
and	NULL
SPI	NULL
Activities	NULL
in	NULL
Erythroid	NULL
Progenitors	NULL
Derived	NULL
from	NULL
CBL	NULL
To	NULL
gain	NULL
an	NULL
insight	NULL
into	NULL
the	NULL
mechanism	NULL
of	NULL
hemoglobin	NULL
switching	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
factors	NULL
GATA-1	NULL
and	NULL
SPI	NULL
in	NULL
differentiating	NULL
progenitors	NULL
derived	NULL
from	NULL
CBL	NULL
.	NULL

Samples	NULL
of	NULL
CBL	NULL
were	NULL
grown	NULL
in	NULL
the	NULL
two-phase	NULL
liquid	NULL
culture	NULL
system	NULL
(	NULL
4	NULL
)	NULL
.	NULL

In	NULL
the	NULL
first	NULL
phase	NULL
,	NULL
mononuclear	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
conditioned	NULL
medium	NULL
containing	NULL
hemapoi-etic	NULL
growth	NULL
factors	NULL
not	NULL
including	NULL
EPO	NULL
.	NULL

EPO	NULL
was	NULL
added	NULL
at	NULL
the	NULL
beginning	NULL
of	NULL
the	NULL
second	NULL
phase	NULL
.	NULL

Samples	NULL
were	NULL
taken	NULL
at	NULL
different	NULL
time	NULL
points	NULL
,	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

We	NULL
found	NULL
that	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
adult	NULL
cultures	NULL
,	NULL
high	NULL
levels	NULL
of	NULL
GATA-1	NULL
binding	NULL
activity	NULL
were	NULL
present	NULL
on	NULL
Days	NULL
7-12	NULL
(	NULL
Fig	NULL
.	NULL

la	NULL
and	NULL
b	NULL
)	NULL
.	NULL

However	NULL
,	NULL
while	NULL
the	NULL
level	NULL
of	NULL
SPI	NULL
in	NULL
the	NULL
adult	NULL
cultures	NULL
rose	NULL
in	NULL
parallel	NULL
to	NULL
that	NULL
of	NULL
GATA-1	NULL
(	NULL
5	NULL
)	NULL
(	NULL
see	NULL
also	NULL
Fig	NULL
.	NULL

3d	NULL
)	NULL
,	NULL
in	NULL
the	NULL
CBL	NULL
culture	NULL
SP1	NULL
was	NULL
very	NULL
low	NULL
on	NULL
Days	NULL
7	NULL
and	NULL
9	NULL
,	NULL
and	NULL
increased	NULL
substantially	NULL
,	NULL
to	NULL
adult	NULL
level	NULL
,	NULL
only	NULL
on	NULL
Day	NULL
12	NULL
.	NULL

These	NULL
observations	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
notion	NULL
that	NULL
CBL	NULL
contains	NULL
a	NULL
mixture	NULL
of	NULL
adult	NULL
and	NULL
fetal	NULL
progenitors	NULL
.	NULL

We	NULL
concluded	NULL
that	NULL
the	NULL
high	NULL
GATA-1	NULL
and	NULL
SPI	NULL
(	NULL
seen	NULL
on	NULL
Day	NULL
12	NULL
)	NULL
characterize	NULL
the	NULL
adult	NULL
progenitors	NULL
present	NULL
in	NULL
the	NULL
culture	NULL
,	NULL
which	NULL
appear	NULL
to	NULL
differentiate	NULL
more	NULL
slowly	NULL
than	NULL
the	NULL
fetal	NULL
progenitors	NULL
.	NULL

We	NULL
attributed	NULL
the	NULL
high	NULL
GATA-1/low	NULL
SPI	NULL
activities	NULL
seen	NULL
on	NULL
Days	NULL
7-9	NULL
to	NULL
the	NULL
differentiating	NULL
fetal	NULL
cells	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
results	NULL
implied	NULL
that	NULL
the	NULL
fetal	NULL
erythroid	NULL
differentiation	NULL
program	NULL
is	NULL
associated	NULL
with	NULL
high	NULL
GATA-1	NULL
activity	NULL
and	NULL
low	NULL
SPI	NULL
.	NULL

Differentiation	NULL
of	NULL
Fetal	NULL
Liver	NULL
Progenitors	NULL
in	NULL
Liquid	NULL
Culture	NULL
To	NULL
obtain	NULL
more	NULL
direct	NULL
evidence	NULL
we	NULL
proceeded	NULL
to	NULL
investigate	NULL
differentiating	NULL
erythroid	NULL
cultures	NULL
derived	NULL
from	NULL
midgestation	NULL
human	NULL
fetal	NULL
livers	NULL
,	NULL
as	NULL
a	NULL
source	NULL
of	NULL
pure	NULL
fetal	NULL
progenitors	NULL
.	NULL

Livers	NULL
were	NULL
obtained	NULL
from	NULL
aborted	NULL
fetuses	NULL
(	NULL
Week	NULL
19-20	NULL
gestational	NULL
age	NULL
)	NULL
and	NULL
single-cell	NULL
suspensions	NULL
were	NULL
prepared	NULL
.	NULL

Those	NULL
included	NULL
a	NULL
large	NULL
proportion	NULL
of	NULL
nucleated	NULL
,	NULL
hemoglobinized	NULL
erythroid	NULL
cells	NULL
(	NULL
orthochromatic	NULL
normoblasts	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
plated	NULL
with	NULL
conditioned	NULL
medium	NULL
(	NULL
Day	NULL
-7	NULL
)	NULL
.	NULL

Three	NULL
days	NULL
later	NULL
(	NULL
Day	NULL
-4	NULL
)	NULL
a	NULL
small	NULL
number	NULL
of	NULL
nonhemoglobinized	NULL
erythroid	NULL
cells	NULL
(	NULL
pronormo-blasts	NULL
and	NULL
basophilic	NULL
normoblasts	NULL
)	NULL
appeared	NULL
.	NULL

Those	NULL
were	NULL
presumably	NULL
cells	NULL
that	NULL
were	NULL
beyond	NULL
the	NULL
CFUe	NULL
stage	NULL
,	NULL
and	NULL
already	NULL
EPO-induced	NULL
,	NULL
when	NULL
placed	NULL
in	NULL
culture	NULL
.	NULL

During	NULL
the	NULL
first	NULL
phase	NULL
,	NULL
the	NULL
number	NULL
of	NULL
the	NULL
nucleated	NULL
erythroid	NULL
cells	NULL
decreased	NULL
dramatically	NULL
,	NULL
due	NULL
to	NULL
enuclation	NULL
of	NULL
the	NULL
orthochromatic	NULL
normoblasts	NULL
and	NULL
cell	NULL
death	NULL
.	NULL

The	NULL
early	NULL
erythroblasts	NULL
,	NULL
which	NULL
were	NULL
visible	NULL
on	NULL
Day	NULL
-4	NULL
,	NULL
did	NULL
not	NULL
give	NULL
rise	NULL
to	NULL
hemoglobinized	NULL
cells	NULL
,	NULL
since	NULL
they	NULL
probably	NULL
died	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
EPO	NULL
.	NULL

After	NULL
EPO	NULL
addition	NULL
(	NULL
Day	NULL
0	NULL
)	NULL
significant	NULL
erythroid	NULL
proliferation	NULL
and	NULL
differentiation	NULL
ensued	NULL
.	NULL

The	NULL
differentiation	NULL
of	NULL
a	NULL
representative	NULL
culture	NULL
after	NULL
EPO	NULL
addition	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2a	NULL
.	NULL

Globin	NULL
mRNA	NULL
was	NULL
analyzed	NULL
by	NULL
the	NULL
RT-PCR	NULL
procedure	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

2b	NULL
,	NULL
cells	NULL
from	NULL
the	NULL
first	NULL
phase	NULL
contained	NULL
both	NULL
B-	NULL
and	NULL
y-mRNA	NULL
(	NULL
Days	NULL
-4	NULL
300	NULL
Molecular	NULL
Medicine	NULL
,	NULL
Volume	NULL
1	NULL
,	NULL
Number	NULL
3	NULL
,	NULL
March	NULL
1995	NULL
a	NULL
GATA-1	NULL
SP1	NULL
r	NULL
71	NULL
Day	NULL
K562	NULL
7	NULL
9	NULL
12	NULL
9	NULL
K562	NULL
7	NULL
9	NULL
12	NULL
9°	NULL
5	NULL
s	NULL
f-	NULL
r	NULL
--	NULL
3	NULL
Competition	NULL
mo	NULL
pos	NULL
-	NULL
8	NULL
po-	NULL
po-	NULL
-	NULL
-	NULL
o	NULL
j-SP1	NULL
GATA-1	NULL
~-b	NULL
5	NULL
leat	NULL
=	NULL
41	NULL
»	NULL
/	NULL
‘	NULL
\	NULL
hel	NULL
v	NULL
/	NULL
(	NULL
C	NULL
y	NULL
&	NULL
‘	NULL
3	NULL
C0	NULL
``	NULL
G	NULL
fast	NULL
mm	NULL
27	NULL
O-A	NULL
Ao	NULL
go-6	NULL
-	NULL
7	NULL
8	NULL
-	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
D	NULL
a	NULL
y	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Analysis	NULL
of	NULL
transcription	NULL
factors	NULL
GATA-1	NULL
and	NULL
SPI	NULL
in	NULL
CBL	NULL
culture	NULL
,	NULL
second	NULL
phase	NULL
(	NULL
a	NULL
)	NULL
Autoradiogram	NULL
of	NULL
gel	NULL
retardation	NULL
assay	NULL
.	NULL

The	NULL
numbers	NULL
on	NULL
top	NULL
represent	NULL
days	NULL
in	NULL
the	NULL
second	NULL
phase	NULL
,	NULL
after	NULL
EPO	NULL
addition	NULL
.	NULL

K562	NULL
,	NULL
an	NULL
erythroleukemia	NULL
cell	NULL
line	NULL
serving	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
;	NULL
competition	NULL
,	NULL
binding	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
competitor	NULL
oligonucleotide	NULL
.	NULL

The	NULL
lower	NULL
band	NULL
in	NULL
the	NULL
SP1	NULL
retardation	NULL
assay	NULL
,	NULL
which	NULL
comigrates	NULL
with	NULL
the	NULL
GATA-1	NULL
-shifted	NULL
band	NULL
,	NULL
is	NULL
probably	NULL
due	NULL
to	NULL
nonspecific	NULL
binding	NULL
(	NULL
17	NULL
)	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Quantitative	NULL
analysis	NULL
of	NULL
the	NULL
autora-diograms	NULL
.	NULL

@	NULL
,	NULL
GATA-1	NULL
binding	NULL
activity	NULL
;	NULL
O	NULL
,	NULL
SP1	NULL
binding	NULL
activity	NULL
.	NULL

and	NULL
0	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
they	NULL
included	NULL
both	NULL
fetal-type	NULL
and	NULL
adult-type	NULL
cells	NULL
.	NULL

The	NULL
adult-type	NULL
cells	NULL
in	NULL
the	NULL
fetal	NULL
liver	NULL
were	NULL
presumably	NULL
derived	NULL
from	NULL
the	NULL
circulating	NULL
fetal	NULL
blood	NULL
.	NULL

At	NULL
this	NULL
gestational	NULL
age	NULL
,	NULL
approximately	NULL
10	NULL
%	NULL
of	NULL
the	NULL
hemoglobin	NULL
in	NULL
the	NULL
fetal	NULL
blood	NULL
is	NULL
adult	NULL
hemoglobin	NULL
(	NULL
normal	NULL
B/y-chain	NULL
synthesis	NULL
ratio	NULL
is	NULL
~10	NULL
%	NULL
[	NULL
18	NULL
]	NULL
)	NULL
.	NULL

In	NULL
the	NULL
second	NULL
phase	NULL
,	NULL
the	NULL
cells	NULL
contained	NULL
only	NULL
y-globin	NULL
mRNA	NULL
(	NULL
Fig	NULL
.	NULL

2¢	NULL
,	NULL
Days	NULL
5	NULL
and	NULL
8	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
those	NULL
cells	NULL
were	NULL
derived	NULL
from	NULL
pure	NULL
fetal	NULL
progenitors	NULL
.	NULL

The	NULL
343	NULL
bp	NULL
band	NULL
corresponds	NULL
to	NULL
the	NULL
un-spliced	NULL
y-RNA	NULL
(	NULL
or	NULL
DNA	NULL
)	NULL
.	NULL

Analyses	NULL
of	NULL
GATA-1	NULL
and	NULL
SP1	NULL
Activities	NULL
in	NULL
the	NULL
Fetal	NULL
Liver	NULL
Cultures	NULL
Nuclear	NULL
proteins	NULL
were	NULL
extracted	NULL
and	NULL
assayed	NULL
for	NULL
the	NULL
levels	NULL
of	NULL
GATA-1	NULL
and	NULL
SP1	NULL
by	NULL
the	NULL
gel	NULL
retardation	NULL
assay	NULL
using	NULL
end-labeled	NULL
double-stranded	NULL
oligonucleotides	NULL
containing	NULL
either	NULL
binding	NULL
site	NULL
.	NULL

The	NULL
results	NULL
obtained	NULL
from	NULL
the	NULL
fetal	NULL
liver	NULL
culture	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
are	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

3a	NULL
and	NULL
b	NULL
,	NULL
and	NULL
summarized	NULL
graphically	NULL
in	NULL
Fig	NULL
.	NULL

3¢	NULL
.	NULL

Two	NULL
additional	NULL
fetal	NULL
liver	NULL
cultures	NULL
gave	NULL
similar	NULL
results	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

EPO	NULL
was	NULL
added	NULL
on	NULL
Day	NULL
0	NULL
.	NULL

This	NULL
was	NULL
followed	NULL
by	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
level	NULL
of	NULL
GATA-1	NULL
,	NULL
with	NULL
a	NULL
peak	NULL
on	NULL
Day	NULL
6	NULL
,	NULL
while	NULL
the	NULL
level	NULL
of	NULL
SPI	NULL
remained	NULL
low	NULL
throughout	NULL
the	NULL
culture	NULL
period	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
adult	NULL
cultures	NULL
,	NULL
in	NULL
which	NULL
SPI	NULL
activity	NULL
was	NULL
significantly	NULL
higher	NULL
and	NULL
its	NULL
kinetics	NULL
paralleled	NULL
that	NULL
of	NULL
GATA-1	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

3¢	NULL
and	NULL
d	NULL
)	NULL
.	NULL

For	NULL
comparison	NULL
,	NULL
binding	NULL
activity	NULL
of	NULL
GATA-1	NULL
and	NULL
SP1	NULL
of	NULL
a	NULL
normal	NULL
adult-derived	NULL
culture	NULL
grown	NULL
,	NULL
harvested	NULL
and	NULL
analyzed	NULL
in	NULL
parallel	NULL
to	NULL
the	NULL
fetal	NULL
liver	NULL
culture	NULL
is	NULL
shown	NULL
in	NULL
Lanes	NULL
14-15	NULL
(	NULL
Days	NULL
5	NULL
and	NULL
7	NULL
)	NULL
in	NULL
Fig	NULL
.	NULL

3a	NULL
and	NULL
b	NULL
.	NULL

In	NULL
the	NULL
fetal	NULL
liver	NULL
cells	NULL
harvested	NULL
on	NULL
Day	NULL
-7	NULL
,	NULL
when	NULL
the	NULL
culture	NULL
first	NULL
started	NULL
,	NULL
the	NULL
levels	NULL
of	NULL
both	NULL
transcription	NULL
factors	NULL
were	NULL
high	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
adult-type	NULL
B-globin	NULL
expressing	NULL
cells	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
both	NULL
transcription	NULL
factors	NULL
decreased	NULL
as	NULL
those	NULL
(	NULL
presum-ably	NULL
BM-derived	NULL
)	NULL
cells	NULL
matured	NULL
.	NULL

Before	NULL
replating	NULL
the	NULL
cells	NULL
in	NULL
the	NULL
second	NULL
phase	NULL
(	NULL
Day	NULL
0	NULL
)	NULL
,	NULL
the	NULL
culture	NULL
was	NULL
divided	NULL
,	NULL
and	NULL
part	NULL
was	NULL
grown	NULL
without	NULL
EPO	NULL
.	NULL

Neither	NULL
GATA-1	NULL
nor	NULL
SPI	NULL
activities	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
EPO	NULL
throughout	NULL
the	NULL
culture	NULL
period	NULL
(	NULL
Lanes	NULL
16-19	NULL
,	NULL
Fig	NULL
.	NULL

3a	NULL
and	NULL
b	NULL
)	NULL
.	NULL

Those	NULL
nuclear	NULL
extracts	NULL
were	NULL
positive	NULL
for	NULL
the	NULL
ubiquitous	NULL
transcription	NULL
factor	NULL
OTF-1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
which	NULL
served	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
for	NULL
nuclear	NULL
protein	NULL
extraction	NULL
.	NULL

These	NULL
results	NULL
corroborate	NULL
that	NULL
GATA-1	NULL
binding	NULL
activity	NULL
is	NULL
EPO	NULL
dependent	NULL
.	NULL

The	NULL
experiments	NULL
demonstrate	NULL
that	NULL
high	NULL
SPI	NULL
activity	NULL
is	NULL
not	NULL
involved	NULL
in	NULL
late	NULL
fetal	NULL
erythroid	NULL
E.	NULL
R.	NULL
Bacon	NULL
et	NULL
al	NULL
.	NULL

:	NULL
Transcription	NULL
Factors	NULL
in	NULL
Hemoglobin	NULL
Switching	NULL
301	NULL
a	NULL
12s	NULL
]	NULL
==	NULL
b	NULL
y-globin	NULL
-globin	NULL
C	NULL
y-globin	NULL
B-globin	NULL
|	NULL
_	NULL
]	NULL
a	NULL
3	NULL
'	NULL
u	NULL
<	NULL
x	NULL
i	NULL
&	NULL
o	NULL
4	NULL
Fetal	NULL
Z2	NULL
n	NULL
E	NULL
Fetal	NULL
f	NULL
;	NULL
(	NULL
J	NULL
Fetal	NULL
5	NULL
3	NULL
Fetal	NULL
5	NULL
~	NULL
1001	NULL
#	NULL
2	NULL
A	NULL
ps	NULL
C	NULL
a	NULL
e.	NULL
,	NULL
)	NULL
ok	NULL
R	NULL
o	NULL
ZKj	NULL
Day	NULL
»	NULL
7-4	NULL
o	NULL
g	NULL
8	NULL
8-4	NULL
0	NULL
g	NULL
m	NULL
Day	NULL
M	NULL
2	NULL
5	NULL
8	NULL
g	NULL
3	NULL
5s	NULL
8	NULL
g	NULL
M	NULL
e	NULL
|	NULL
g	NULL
**	NULL
}	NULL
|	NULL
w	NULL
|	NULL
A	NULL
|	NULL
Z	NULL
507	NULL
)	NULL
|	NULL
§	NULL
|	NULL
X	NULL
a	NULL
4	NULL
hel	NULL
A	NULL
1	NULL
297	NULL
|_	NULL
*	NULL
¢	NULL
-	NULL
o-	NULL
£04	NULL
|	NULL
/*	NULL
&	NULL
``	NULL
y	NULL
``	NULL
C	NULL
#	NULL
|	NULL
210-	NULL
[	NULL
-t	NULL
&	NULL
-	NULL
-O-	NULL
]	NULL
a	NULL
0	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Differentiation	NULL
of	NULL
cultured	NULL
erythroid	NULL
progenitors	NULL
derived	NULL
from	NULL
fetal	NULL
liver	NULL
{	NULL
a	NULL
)	NULL
Morphological	NULL
studies	NULL
,	NULL
second	NULL
phase	NULL
.	NULL

The	NULL
graphs	NULL
represent	NULL
the	NULL
number	NULL
of	NULL
cells	NULL
per	NULL
2	NULL
X	NULL
10°	NULL
nucleated	NULL
cells	NULL
harvested	NULL
at	NULL
each	NULL
time	NULL
point	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
EPO	NULL
on	NULL
Day	NULL
0	NULL
.	NULL

O	NULL
,	NULL
nonhemoglobinized	NULL
erythroid	NULL
cells	NULL
(	NULL
pronormo-blasts	NULL
and	NULL
basophilic	NULL
normoblasts	NULL
)	NULL
;	NULL
@	NULL
,	NULL
Partially	NULL
hemoglobinized	NULL
erythroid	NULL
cells	NULL
(	NULL
polychromatophilic	NULL
normoblasts	NULL
)	NULL
;	NULL
A	NULL
,	NULL
Fully	NULL
hemoglobinized	NULL
cells	NULL
(	NULL
orthochromatic	NULL
normoblasts	NULL
}	NULL
.	NULL

(	NULL
b	NULL
and	NULL
c	NULL
)	NULL
RNA	NULL
analyses	NULL
of	NULL
first	NULL
and	NULL
second	NULL
phase	NULL
of	NULL
the	NULL
fetal	NULL
liver	NULL
culture	NULL
,	NULL
respectively	NULL
.	NULL

Total	NULL
cytoplasmic	NULL
RNA	NULL
was	NULL
harvested	NULL
and	NULL
aliquots	NULL
of	NULL
the	NULL
same	NULL
RNA	NULL
samples	NULL
were	NULL
analyzed	NULL
by	NULL
RT-PCR	NULL
for	NULL
either	NULL
y-globin	NULL
mRNA	NULL
(	NULL
210	NULL
bp	NULL
amplification	NULL
product	NULL
)	NULL
or	NULL
for	NULL
B-globin	NULL
mRNA	NULL
(	NULL
297	NULL
bp	NULL
)	NULL
.	NULL

The	NULL
numbers	NULL
represent	NULL
days	NULL
in	NULL
culture	NULL
.	NULL

K562	NULL
RNA	NULL
served	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
for	NULL
y-mRNA	NULL
;	NULL
adult	NULL
culture	NULL
derived	NULL
RNA	NULL
,	NULL
purified	NULL
from	NULL
a	NULL
sample	NULL
harvested	NULL
on	NULL
Day	NULL
5	NULL
,	NULL
served	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
for	NULL
B-mRNA	NULL
.	NULL

M	NULL
,	NULL
DNA	NULL
size	NULL
marker	NULL
.	NULL

differentiation	NULL
.	NULL

We	NULL
,	NULL
therefore	NULL
,	NULL
concluded	NULL
that	NULL
fetal	NULL
progenitors	NULL
are	NULL
distinct	NULL
from	NULL
adult	NULL
progenitors	NULL
not	NULL
only	NULL
in	NULL
their	NULL
globin	NULL
mRNA	NULL
species	NULL
but	NULL
also	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
GATA-2	NULL
has	NULL
the	NULL
same	NULL
binding	NULL
specificity	NULL
as	NULL
GATA-1	NULL
.	NULL

It	NULL
has	NULL
been	NULL
demonstrated	NULL
,	NULL
by	NULL
gene	NULL
targeting	NULL
experiments	NULL
in	NULL
mouse	NULL
embryonic	NULL
stem	NULL
cells	NULL
,	NULL
that	NULL
GATA-2	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
early	NULL
hematopoiesis	NULL
,	NULL
particularly	NULL
of	NULL
the	NULL
adult	NULL
type	NULL
(	NULL
19	NULL
)	NULL
.	NULL

We	NULL
tested	NULL
the	NULL
fetal	NULL
culture	NULL
for	NULL
presence	NULL
of	NULL
GATA-2	NULL
RNA	NULL
by	NULL
RT-PCR	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Some	NULL
GATA-2	NULL
mRNA	NULL
was	NULL
observed	NULL
during	NULL
the	NULL
first	NULL
phase	NULL
of	NULL
the	NULL
culture	NULL
,	NULL
supporting	NULL
the	NULL
suggested	NULL
role	NULL
of	NULL
GATA-2	NULL
.	NULL

After	NULL
EPO	NULL
addition	NULL
,	NULL
only	NULL
GATA-1	NULL
and	NULL
no	NULL
GATA-2	NULL
mRNA	NULL
was	NULL
detected	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Recruitment	NULL
of	NULL
Fetal	NULL
Progenitors	NULL
in	NULL
Adulthood	NULL
Some	NULL
forms	NULL
of	NULL
high	NULL
HbF	NULL
production	NULL
in	NULL
adults	NULL
are	NULL
associated	NULL
with	NULL
anemic	NULL
stress	NULL
,	NULL
and	NULL
are	NULL
thus	NULL
expressed	NULL
only	NULL
in	NULL
patients	NULL
with	NULL
B-thalassemia	NULL
or	NULL
sickle	NULL
cell	NULL
anemia	NULL
but	NULL
not	NULL
in	NULL
their	NULL
parents	NULL
or	NULL
carrier	NULL
siblings	NULL
.	NULL

A	NULL
possible	NULL
mechanism	NULL
is	NULL
the	NULL
recruitment	NULL
of	NULL
fetal	NULL
cells	NULL
,	NULL
induced	NULL
by	NULL
the	NULL
anemic	NULL
stress	NULL
.	NULL

The	NULL
ability	NULL
to	NULL
distinguish	NULL
between	NULL
fetal	NULL
and	NULL
adult	NULL
erythroid	NULL
cells	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
factor	NULL
allows	NULL
the	NULL
testing	NULL
of	NULL
this	NULL
hypothesis	NULL
.	NULL

We	NULL
analyzed	NULL
GATA-1	NULL
and	NULL
SPI	NULL
in	NULL
erythroid	NULL
cultures	NULL
derived	NULL
from	NULL
peripheral	NULL
blood	NULL
of	NULL
three	NULL
B°-thalassemia	NULL
patients	NULL
,	NULL
carrying	NULL
$	NULL
B°	NULL
mutations	NULL
.	NULL

These	NULL
usually	NULL
have	NULL
severe	NULL
clinical	NULL
presentation	NULL
because	NULL
of	NULL
the	NULL
complete	NULL
absence	NULL
of	NULL
B-globin	NULL
chains	NULL
.	NULL

Patient	NULL
A	NULL
(	NULL
Fig	NULL
.	NULL

4a	NULL
)	NULL
,	NULL
homozygous	NULL
for	NULL
the	NULL
-globin	NULL
mutation	NULL
IVS2-1	NULL
,	NULL
has	NULL
a	NULL
mild	NULL
form	NULL
of	NULL
thalassemia	NULL
(	NULL
intermedia	NULL
)	NULL
owing	NULL
to	NULL
very	NULL
high	NULL
HbF	NULL
production	NULL
(	NULL
y/a	NULL
chain	NULL
synthesis	NULL
ratio	NULL
0.42	NULL
at	NULL
the	NULL
age	NULL
of	NULL
27	NULL
years	NULL
)	NULL
.	NULL

His	NULL
high	NULL
HbF	NULL
production	NULL
in	NULL
adulthood	NULL
is	NULL
not	NULL
due	NULL
to	NULL
y-globin	NULL
promoter	NULL
mutations	NULL
but	NULL
to	NULL
an	NULL
unidentified	NULL
factor	NULL
that	NULL
functions	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anemic	NULL
stress	NULL
(	NULL
20	NULL
)	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
his	NULL
cultured	NULL
erythroid	NULL
cells	NULL
present	NULL
a	NULL
``	NULL
fetal	NULL
``	NULL
pattern	NULL
(	NULL
high	NULL
GATA-1/low	NULL
SP1	NULL
levels	NULL
)	NULL
,	NULL
supporting	NULL
the	NULL
model	NULL
of	NULL
persistent	NULL
recruitment	NULL
of	NULL
fetal	NULL
progenitors	NULL
in	NULL
adulthood	NULL
.	NULL

Additional	NULL
evidence	NULL
comes	NULL
from	NULL
other	NULL
parameters	NULL
associated	NULL
with	NULL
fetal	NULL
erythropoiesis	NULL
:	NULL
high	NULL
titer	NULL
of	NULL
i	NULL
antigen	NULL
,	NULL
an	NULL
elevated	NULL
level	NULL
of	NULL
Gy	NULL
(	NULL
42	NULL
%	NULL
)	NULL
and	NULL
extensive	NULL
(	NULL
40	NULL
%	NULL
)	NULL
y-globin	NULL
DNA	NULL
hypomethylation	NULL
(	NULL
in	NULL
his	NULL
erythroid	NULL
cells	NULL
)	NULL
(	NULL
21	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
his	NULL
niece	NULL
(	NULL
Patient	NULL
B	NULL
,	NULL
Fig	NULL
.	NULL

4h	NULL
)	NULL
,	NULL
who	NULL
is	NULL
also	NULL
homozygous	NULL
for	NULL
the	NULL
same	NULL
B-globin	NULL
mutation	NULL
,	NULL
has	NULL
a	NULL
severe	NULL
clinical	NULL
form	NULL
of	NULL
thalassemia	NULL
(	NULL
major	NULL
)	NULL
without	NULL
high	NULL
HbF	NULL
(	NULL
y/a	NULL
chain	NULL
synthesis	NULL
ratio	NULL
0.24	NULL
at	NULL
the	NULL
age	NULL
of	NULL
2	NULL
years	NULL
)	NULL
.	NULL

Because	NULL
of	NULL
the	NULL
low	NULL
number	NULL
of	NULL
cells	NULL
,	NULL
only	NULL
two	NULL
time	NULL
points	NULL
were	NULL
analyzed	NULL
.	NULL

Her	NULL
culture	NULL
differentiated	NULL
rapidly	NULL
,	NULL
and	NULL
the	NULL
samples	NULL
represent	NULL
the	NULL
later	NULL
stages	NULL
of	NULL
erythroid	NULL
differentiation	NULL
.	NULL

Nevertheless	NULL
,	NULL
it	NULL
can	NULL
be	NULL
seen	NULL
that	NULL
she	NULL
presents	NULL
``	NULL
adult	NULL
``	NULL
pattern	NULL
of	NULL
transcription	NULL
factors	NULL
(	NULL
sig-nificant	NULL
SP1	NULL
activity	NULL
,	NULL
which	NULL
parallels	NULL
GATA-1	NULL
)	NULL
.	NULL

Likewise	NULL
,	NULL
an	NULL
unrelated	NULL
patient	NULL
(	NULL
Patient	NULL
C	NULL
,	NULL
Fig	NULL
.	NULL

4¢	NULL
)	NULL
with	NULL
a	NULL
B-globin	NULL
genotype	NULL
IVS2-1/FS44	NULL
and	NULL
low	NULL
302	NULL
Molecular	NULL
Medicine	NULL
,	NULL
Volume	NULL
1	NULL
,	NULL
Number	NULL
3	NULL
,	NULL
March	NULL
1995	NULL
Adult	NULL
G	NULL
a	NULL
K562	NULL
Fetal	NULL
_	NULL
liver	NULL
blood	NULL
Fetal	NULL
liver	NULL
Epo	NULL
TCI	NULL
$	NULL
%	NULL
+	NULL
%	NULL
&	NULL
%	NULL
£	NULL
i	NULL
#	NULL
#	NULL
go	NULL
>	NULL
_	NULL
.	NULL

.	NULL
``	NULL

6	NULL
7	NULL
8	NULL
9	NULL
6	NULL
S	NULL
7	NULL
2	NULL
4	NULL
5	NULL
8	NULL
8	NULL
Day	NULL
7	NULL
100	NULL
20	NULL
4	NULL
5	NULL
GATA-1	NULL
-	NULL
»	NULL
’	NULL
'	NULL
5	NULL
‘	NULL
``	NULL
#	NULL
®	NULL
``	NULL
%	NULL
.	NULL

te	NULL
#	NULL
«	NULL
Binding	NULL
activity	NULL
N	NULL
1	NULL
*	NULL
Epo	NULL
Free	NULL
-	NULL
»	NULL
.	NULL

.	NULL

1	NULL
~	NULL
probe	NULL
silts	NULL
is	NULL
1	NULL
2	NULL
304	NULL
5	NULL
60	NULL
7	NULL
$	NULL
09	NULL
10	NULL
H	NULL
12	NULL
13	NULL
14	NULL
Is	NULL
d6	NULL
17	NULL
18	NULL
io	NULL
O	NULL
j	NULL
T	NULL
*	NULL
T-*~4	NULL
Lii	NULL
Toe	NULL
j	NULL
T	NULL
'-	NULL
3	NULL
*	NULL
I	NULL
J	NULL
I	NULL
Adult	NULL
b	NULL
K562_____	NULL
Fetal	NULL
_	NULL
liver	NULL
blood	NULL
Fetal	NULL
liver	NULL
Epo	NULL
TI	NULL
I	NULL
£	NULL
+t	NULL
+	NULL
+o	NULL
£	NULL
£	NULL
or	NULL
i	NULL
'	NULL
;	NULL
as*	NULL
Day	NULL
100	NULL
2	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
60	NULL
5	NULL
7	NULL
2	NULL
4	NULL
5	NULL
8	NULL
:	NULL
3	NULL
4	NULL
)	NULL
Q	NULL
,	NULL
6	NULL
SP1	NULL
-	NULL
»	NULL
..	NULL
,	NULL
w	NULL
9	NULL
’	NULL
§	NULL
b	NULL
%	NULL
``	NULL
/	NULL
@	NULL
e	NULL
%	NULL
&	NULL
i	NULL
he	NULL
4	NULL
|	NULL
.	NULL

a	NULL
.	NULL

3	NULL
%	NULL
Ra-	NULL
;	NULL
&	NULL
ma	NULL
Free	NULL
0	NULL
2	NULL
4	NULL
6	NULL
8	NULL
10	NULL
12	NULL
14	NULL
probe	NULL
f	NULL
£050	NULL
607	NULL
8	NULL
9	NULL
10	NULL
1112	NULL
1G	NULL
M	NULL
1s	NULL
16	NULL
17	NULL
18	NULL
19	NULL
Day	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Transcription	NULL
factors	NULL
GATA-1	NULL
and	NULL
SPI	NULL
in	NULL
differentiating	NULL
fetal	NULL
erythroid	NULL
cells	NULL
The	NULL
free	NULL
probe	NULL
and	NULL
the	NULL
shifted	NULL
bands	NULL
are	NULL
indicated	NULL
by	NULL
the	NULL
arrows	NULL
.	NULL

The	NULL
day	NULL
of	NULL
harvest	NULL
and	NULL
EPO	NULL
addition	NULL
are	NULL
shown	NULL
.	NULL

above	NULL
.	NULL

The	NULL
lanes	NULL
are	NULL
numbered	NULL
below	NULL
.	NULL

(	NULL
a	NULL
)	NULL
GATA-1	NULL
binding	NULL
activity	NULL
.	NULL

(	NULL
b	NULL
)	NULL
SP1	NULL
binding	NULL
activity	NULL
.	NULL

Lanes	NULL
1	NULL
and	NULL
2	NULL
,	NULL
nuclear	NULL
extracts	NULL
of	NULL
K562	NULL
cells	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
;	NULL
Lanes	NULL
2	NULL
and	NULL
13	NULL
(	NULL
designated	NULL
c	NULL
)	NULL
,	NULL
cold	NULL
competition-binding	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotide	NULL
;	NULL
Lanes	NULL
3-13	NULL
,	NULL
fetal	NULL
liver	NULL
cultures	NULL
,	NULL
first	NULL
and	NULL
second	NULL
phase	NULL
;	NULL
Lanes	NULL
14	NULL
and	NULL
15	NULL
,	NULL
binding	NULL
activity	NULL
of	NULL
nuclear	NULL
extracts	NULL
of	NULL
a	NULL
normal	NULL
adult-derived	NULL
culture	NULL
grown	NULL
,	NULL
harvested	NULL
and	NULL
analyzed	NULL
in	NULL
parallel	NULL
to	NULL
the	NULL
fetal	NULL
liver	NULL
culture	NULL
;	NULL
Lanes	NULL
16-19	NULL
,	NULL
nuclear	NULL
extracts	NULL
of	NULL
a	NULL
parallel	NULL
culture	NULL
of	NULL
the	NULL
same	NULL
liver	NULL
,	NULL
grown	NULL
in	NULL
the	NULL
second	NULL
phase	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
EPO	NULL
.	NULL

(	NULL
c	NULL
)	NULL
Quantification	NULL
of	NULL
the	NULL
autoradiograms	NULL
(	NULL
shown	NULL
in	NULL
a	NULL
and	NULL
b	NULL
)	NULL
.	NULL

(	NULL
d	NULL
)	NULL
GATA-1	NULL
and	NULL
SP1	NULL
binding	NULL
activities	NULL
of	NULL
a	NULL
normal	NULL
adult-derived	NULL
culture	NULL
.	NULL

@	NULL
,	NULL
GATA-1	NULL
binding	NULL
activity	NULL
;	NULL
O	NULL
,	NULL
SP1	NULL
binding	NULL
activity	NULL
.	NULL

HbF	NULL
(	NULL
y/a	NULL
chain	NULL
synthesis	NULL
ratio	NULL
of	NULL
0.24	NULL
)	NULL
also	NULL
DISCUSSION	NULL
shows	NULL
``	NULL
adult	NULL
``	NULL
pattern	NULL
.	NULL

It	NULL
appears	NULL
that	NULL
not	NULL
all	NULL
B-thalassemia	NULL
patients	NULL
are	NULL
capable	NULL
of	NULL
significant	NULL
Our	NULL
studies	NULL
demonstrate	NULL
that	NULL
erythroid	NULL
progen-recruitment	NULL
of	NULL
fetal	NULL
progenitors	NULL
.	NULL

Further	NULL
studies	NULL
itors	NULL
derived	NULL
from	NULL
fetal	NULL
liver	NULL
have	NULL
a	NULL
genetic	NULL
pro-are	NULL
needed	NULL
to	NULL
clarify	NULL
the	NULL
mechanism	NULL
underlying	NULL
gram	NULL
that	NULL
is	NULL
distinct	NULL
from	NULL
that	NULL
of	NULL
adult-derived	NULL
this	NULL
phenomenon	NULL
.	NULL

cells	NULL
.	NULL

In	NULL
response	NULL
to	NULL
EPO	NULL
,	NULL
the	NULL
fetal	NULL
erythroblasts	NULL
E.	NULL
R.	NULL
Bacon	NULL
et	NULL
al	NULL
.	NULL

;	NULL
Transcription	NULL
Factors	NULL
in	NULL
Hemoglobin	NULL
Switching	NULL
303	NULL
i	NULL
in	NULL
Binding	NULL
activity	NULL
Hho	NULL
ML	NULL
Y	NULL
,	NULL
®	NULL
0	NULL
``	NULL
T	NULL
T	NULL
T	NULL
3	NULL
4	NULL
5	NULL
6	NULL
8	NULL
C	NULL
54	NULL
4	NULL
3-2-	NULL
r	NULL
r	NULL
r	NULL
r	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
Day	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

GATA-1	NULL
and	NULL
SPI	NULL
activities	NULL
in	NULL
erythroid	NULL
cultures	NULL
derived	NULL
from	NULL
B°-thalassemia	NULL
patients	NULL
(	NULL
a	NULL
)	NULL
Patient	NULL
A	NULL
has	NULL
thalassemia	NULL
intermedia	NULL
due	NULL
to	NULL
elevated	NULL
HbF	NULL
production	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Patient	NULL
B	NULL
is	NULL
the	NULL
niece	NULL
of	NULL
Patient	NULL
A	NULL
.	NULL

She	NULL
is	NULL
transfusion	NULL
dependent	NULL
B-thalassemia	NULL
major	NULL
.	NULL

(	NULL
c	NULL
)	NULL
An	NULL
unrelated	NULL
B-thalassemia	NULL
major	NULL
patient	NULL
.	NULL

@	NULL
,	NULL
GATA-1	NULL
binding	NULL
activity	NULL
;	NULL
O	NULL
,	NULL
SP1	NULL
binding	NULL
activity	NULL
.	NULL

express	NULL
a	NULL
high	NULL
level	NULL
of	NULL
GATA-1	NULL
but	NULL
only	NULL
a	NULL
low	NULL
level	NULL
of	NULL
SP1	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
adult-derived	NULL
cells	NULL
,	NULL
in	NULL
which	NULL
both	NULL
transcription	NULL
factors	NULL
rise	NULL
in	NULL
parallel	NULL
.	NULL

Moreover	NULL
,	NULL
we	NULL
observed	NULL
good	NULL
correlation	NULL
between	NULL
the	NULL
patterns	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
and	NULL
the	NULL
RNA	NULL
species	NULL
present	NULL
.	NULL

High	NULL
GATA-1	NULL
and	NULL
high	NULL
SP1	NULL
correlated	NULL
with	NULL
B-globin	NULL
mRNA	NULL
expression	NULL
,	NULL
as	NULL
was	NULL
seen	NULL
both	NULL
in	NULL
the	NULL
first	NULL
phase	NULL
of	NULL
the	NULL
fetal	NULL
liver	NULL
cultures	NULL
and	NULL
in	NULL
the	NULL
later	NULL
stage	NULL
of	NULL
the	NULL
CBL	NULL
culture	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
Day	NULL
12	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
high	NULL
GATA-1	NULL
and	NULL
low	NULL
SPI	NULL
were	NULL
associated	NULL
with	NULL
only	NULL
y-globin	NULL
mRNA	NULL
expression	NULL
,	NULL
as	NULL
observed	NULL
in	NULL
the	NULL
second	NULL
phase	NULL
of	NULL
the	NULL
fetal	NULL
liver	NULL
cultures	NULL
.	NULL

Our	NULL
experiments	NULL
further	NULL
indicate	NULL
that	NULL
the	NULL
fetal	NULL
and	NULL
adult	NULL
progenitors	NULL
retain	NULL
their	NULL
identities	NULL
when	NULL
present	NULL
together	NULL
in	NULL
the	NULL
same	NULL
environment	NULL
in	NULL
the	NULL
CBL	NULL
cultures	NULL
.	NULL

Thus	NULL
,	NULL
commitment	NULL
to	NULL
the	NULL
adult	NULL
versus	NULL
the	NULL
fetal	NULL
program	NULL
is	NULL
determined	NULL
at	NULL
a	NULL
very	NULL
early	NULL
stage	NULL
of	NULL
differentiation	NULL
,	NULL
probably	NULL
pre-BFUe	NULL
,	NULL
before	NULL
the	NULL
progenitors	NULL
are	NULL
placed	NULL
in	NULL
culture	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
fate	NULL
of	NULL
the	NULL
progenitor	NULL
is	NULL
determined	NULL
by	NULL
effector	NULL
cells	NULL
present	NULL
in	NULL
the	NULL
respective	NULL
erythropoietic	NULL
organ	NULL
(	NULL
liver	NULL
versus	NULL
bone	NULL
marrow	NULL
)	NULL
.	NULL

Hereditary	NULL
persistence	NULL
of	NULL
fetal	NULL
hemoglobin	NULL
(	NULL
HPFH	NULL
)	NULL
in	NULL
adulthood	NULL
may	NULL
be	NULL
induced	NULL
by	NULL
several	NULL
mechanisms	NULL
.	NULL

These	NULL
include	NULL
mutations	NULL
in	NULL
cis	NULL
to	NULL
the	NULL
y-globin	NULL
genes	NULL
(	NULL
promoter	NULL
point	NULL
mutations	NULL
and	NULL
large	NULL
deletions	NULL
in	NULL
the	NULL
B-globin	NULL
gene	NULL
cluster	NULL
)	NULL
as	NULL
well	NULL
as	NULL
unlinked	NULL
genetic	NULL
factors	NULL
(	NULL
22	NULL
and	NULL
references	NULL
cited	NULL
therein	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
HbF	NULL
production	NULL
may	NULL
be	NULL
induced	NULL
by	NULL
anemic	NULL
stress	NULL
.	NULL

The	NULL
pattern	NULL
of	NULL
transcription	NULL
factors	NULL
in	NULL
the	NULL
differentiating	NULL
erythroid	NULL
cells	NULL
of	NULL
Patient	NULL
A	NULL
,	NULL
with	NULL
the	NULL
high	NULL
HbF	NULL
,	NULL
provides	NULL
strong	NULL
evidence	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
fetal	NULL
progenitors	NULL
.	NULL

However	NULL
,	NULL
the	NULL
analyses	NULL
of	NULL
erythroid	NULL
cultures	NULL
of	NULL
the	NULL
other	NULL
patients	NULL
indicate	NULL
that	NULL
this	NULL
is	NULL
not	NULL
a	NULL
general	NULL
phenomenon	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
found	NULL
that	NULL
the	NULL
genetic	NULL
factor	NULL
that	NULL
allows	NULL
high	NULL
HbF	NULL
production	NULL
in	NULL
Patient	NULL
A	NULL
is	NULL
unlinked	NULL
to	NULL
the	NULL
B-globin	NULL
gene	NULL
cluster	NULL
(	NULL
20	NULL
)	NULL
.	NULL

The	NULL
level	NULL
of	NULL
HbF	NULL
production	NULL
in	NULL
patients	NULL
with	NULL
sickle	NULL
cell	NULL
anemia	NULL
and	NULL
B-thalassemia	NULL
is	NULL
of	NULL
high	NULL
clinical	NULL
significance	NULL
,	NULL
since	NULL
y-globin	NULL
peptides	NULL
may	NULL
alleviate	NULL
the	NULL
disease	NULL
symptoms	NULL
.	NULL

Several	NULL
agents	NULL
,	NULL
such	NULL
as	NULL
hydroxyurea	NULL
and	NULL
butyrate	NULL
derivatives	NULL
,	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
increase	NULL
y-globin	NULL
gene	NULL
expression	NULL
in	NULL
adult	NULL
patients	NULL
.	NULL

HbF	NULL
and	NULL
F-reticulocyte	NULL
levels	NULL
in	NULL
sickle	NULL
cell	NULL
anemia	NULL
patients	NULL
were	NULL
found	NULL
to	NULL
increase	NULL
significantly	NULL
48-72	NULL
hr	NULL
after	NULL
the	NULL
administration	NULL
of	NULL
hydroxyurea	NULL
began	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
y-globin	NULL
synthesis	NULL
followed	NULL
the	NULL
administration	NULL
of	NULL
butyrate	NULL
closely	NULL
(	NULL
24	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
the	NULL
function	NULL
of	NULL
these	NULL
drugs	NULL
was	NULL
exerted	NULL
on	NULL
cells	NULL
that	NULL
were	NULL
already	NULL
well	NULL
on	NULL
the	NULL
maturation	NULL
path	NULL
304	NULL
Molecular	NULL
Medicine	NULL
,	NULL
Volume	NULL
1	NULL
,	NULL
Number	NULL
3	NULL
,	NULL
March	NULL
1995	NULL
way	NULL
,	NULL
after	NULL
the	NULL
point	NULL
of	NULL
commitment	NULL
to	NULL
the	NULL
adult	NULL
program	NULL
.	NULL

Furthermore	NULL
,	NULL
experiments	NULL
in	NULL
erythroid	NULL
cultures	NULL
(	NULL
grown	NULL
similarly	NULL
to	NULL
those	NULL
studied	NULL
here	NULL
)	NULL
showed	NULL
that	NULL
both	NULL
hydroxyurea	NULL
and	NULL
butyrate	NULL
derivatives	NULL
significantly	NULL
elevated	NULL
y-globin	NULL
expression	NULL
when	NULL
added	NULL
to	NULL
the	NULL
cultures	NULL
4	NULL
days	NULL
after	NULL
EPO	NULL
(	NULL
25,26	NULL
)	NULL
,	NULL
beyond	NULL
the	NULL
CFUe	NULL
stage	NULL
.	NULL

We	NULL
suggest	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
HbF	NULL
by	NULL
these	NULL
agents	NULL
is	NULL
not	NULL
via	NULL
recruitment	NULL
of	NULL
fetal	NULL
progenitors	NULL
,	NULL
but	NULL
by	NULL
a	NULL
fundamentally	NULL
different	NULL
mechanism	NULL
.	NULL

We	NULL
hypothesize	NULL
that	NULL
the	NULL
adult	NULL
progenitors	NULL
are	NULL
capable	NULL
of	NULL
increased	NULL
HbF	NULL
production	NULL
when	NULL
appropriately	NULL
trig-gered	NULL
.	NULL

In	NULL
the	NULL
adult	NULL
progenitor	NULL
,	NULL
the	NULL
complete	NULL
B-globin	NULL
gene	NULL
domain	NULL
has	NULL
an	NULL
``	NULL
open	NULL
'	NULL
``	NULL
chromatin	NULL
configuration	NULL
due	NULL
to	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
LCR	NULL
(	NULL
27,28	NULL
)	NULL
.	NULL

We	NULL
postulate	NULL
that	NULL
this	NULL
``	NULL
open	NULL
``	NULL
chromatin	NULL
state	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
specific	NULL
repressors	NULL
(	NULL
such	NULL
as	NULL
the	NULL
s-globin	NULL
gene	NULL
silencer	NULL
[	NULL
29	NULL
]	NULL
)	NULL
,	NULL
allows	NULL
y-globin	NULL
gene	NULL
expression	NULL
to	NULL
be	NULL
turned	NULL
on	NULL
in	NULL
response	NULL
to	NULL
nonspecific	NULL
,	NULL
general	NULL
gene	NULL
activators	NULL
.	NULL

Further	NULL
studies	NULL
are	NULL
needed	NULL
to	NULL
clarify	NULL
this	NULL
issue	NULL
,	NULL
which	NULL
has	NULL
important	NULL
therapeutic	NULL
implications	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
are	NULL
grateful	NULL
to	NULL
Prof.	NULL
Eitan	NULL
Fibach	NULL
and	NULL
Dr.	NULL
Deborah	NULL
Rund	NULL
for	NULL
many	NULL
helpful	NULL
and	NULL
stimulating	NULL
discussions	NULL
,	NULL
to	NULL
Dr.	NULL
Arik	NULL
Oppenheim	NULL
for	NULL
a	NULL
critical	NULL
review	NULL
of	NULL
the	NULL
manuscript	NULL
,	NULL
and	NULL
to	NULL
Ms.	NULL
Merav	NULL
Ginsberg	NULL
for	NULL
participating	NULL
in	NULL
preliminary	NULL
studies	NULL
.	NULL

Dr.	NULL
Antonella	NULL
Ronchi	NULL
provided	NULL
oligonucleotides	NULL
for	NULL
GATA-1	NULL
and	NULL
SP1	NULL
analyses	NULL
.	NULL

We	NULL
wish	NULL
to	NULL
thank	NULL
Dr.	NULL
Hana	NULL
Ariel	NULL
for	NULL
assistance	NULL
in	NULL
obtaining	NULL
fetal	NULL
liver	NULL
samples	NULL
,	NULL
the	NULL
staff	NULL
at	NULL
the	NULL
Hadassah	NULL
Hematology	NULL
Day	NULL
Care	NULL
Unit	NULL
for	NULL
patients	NULL
'	NULL
PBL	NULL
samples	NULL
,	NULL
and	NULL
the	NULL
staff	NULL
at	NULL
the	NULL
Maternity	NULL
Ward	NULL
for	NULL
CBL	NULL
samples	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Grant	NULL
91-00055	NULL
from	NULL
the	NULL
United	NULL
States-Israel	NULL
Binational	NULL
Science	NULL
Foundation	NULL
(	NULL
BSF	NULL
)	NULL
,	NULL
Jerusalem	NULL
,	NULL
Israel	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Papayannopoulou	NULL
T	NULL
,	NULL
Kalmantis	NULL
TH	NULL
,	NULL
Stama-tayannopoulos	NULL
G.	NULL
(	NULL
1979	NULL
)	NULL
Cellular	NULL
regulation	NULL
of	NULL
hemoglobin	NULL
switching	NULL
:	NULL
Evidence	NULL
for	NULL
inverse	NULL
relationship	NULL
between	NULL
fetal	NULL
hemoglobin	NULL
synthesis	NULL
and	NULL
degree	NULL
of	NULL
maturity	NULL
of	NULL
human	NULL
erythroid	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
76	NULL
:	NULL
6420-6424	NULL
.	NULL

2	NULL
.	NULL

Alter	NULL
BP	NULL
,	NULL
Weinberg	NULL
RS	NULL
,	NULL
Goldberg	NULL
JD	NULL
,	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
Evidence	NULL
for	NULL
a	NULL
clonal	NULL
model	NULL
for	NULL
hemoglobin	NULL
switching	NULL
.	NULL

Prog	NULL
.	NULL

Clin	NULL
.	NULL

Biol	NULL
.	NULL

Res	NULL
.	NULL

134	NULL
:	NULL
431-442	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15.	NULL
.	NULL

Dalyot	NULL
N	NULL
,	NULL
Fibach	NULL
E	NULL
,	NULL
Rachmilewitz	NULL
EA	NULL
,	NULL
Op-	NULL
penheim	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Adult	NULL
and	NULL
neonatal	NULL
patterns	NULL
of	NULL
human	NULL
globin	NULL
gene	NULL
expression	NULL
are	NULL
recapitulated	NULL
in	NULL
liquid	NULL
cultures	NULL
.	NULL

Exp	NULL
.	NULL

Hematol	NULL
.	NULL

20	NULL
;	NULL
1141-1145	NULL
.	NULL

Fibach	NULL
E	NULL
,	NULL
Manor	NULL
D	NULL
,	NULL
Oppenheim	NULL
A	NULL
,	NULL
Rachmilewitz	NULL
EA	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Proliferation	NULL
and	NULL
maturation	NULL
of	NULL
human	NULL
erythroid	NULL
progenitors	NULL
in	NULL
liquid	NULL
culture	NULL
.	NULL

Blood	NULL
73	NULL
:	NULL
100-103.	NULL
.	NULL

Dalyot	NULL
N	NULL
,	NULL
Fibach	NULL
E	NULL
,	NULL
Ronchi	NULL
A	NULL
,	NULL
Rachmilewitz	NULL
EA	NULL
,	NULL
Ottolenghi	NULL
S	NULL
,	NULL
Oppenheim	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Erythropoietin	NULL
triggers	NULL
a	NULL
burst	NULL
of	NULL
GATA-1	NULL
in	NULL
normal	NULL
human	NULL
erythroid	NULL
cells	NULL
differentiating	NULL
in	NULL
tissue	NULL
culture	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

21	NULL
;	NULL
4031-4037.	NULL
.	NULL

Pevyny	NULL
L	NULL
,	NULL
Simon	NULL
MC	NULL
,	NULL
Robertson	NULL
E	NULL
,	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Erythroid	NULL
differentiation	NULL
in	NULL
chimeric	NULL
mice	NULL
blocked	NULL
by	NULL
a	NULL
targeted	NULL
mutation	NULL
in	NULL
the	NULL
gene	NULL
for	NULL
transcription	NULL
factor	NULL
GATA-1	NULL
.	NULL

Nature	NULL
349	NULL
:	NULL
257-260.	NULL
.	NULL

Simon	NULL
MC	NULL
,	NULL
Pevyny	NULL
L	NULL
,	NULL
Wiles	NULL
MV	NULL
,	NULL
Keller	NULL
G	NULL
,	NULL
Costantini	NULL
F	NULL
,	NULL
Orkin	NULL
SH	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Rescue	NULL
of	NULL
erythroid	NULL
development	NULL
in	NULL
gene	NULL
targeted	NULL
GATA-1	NULL
mouse	NULL
embryonic	NULL
stem	NULL
cells	NULL
.	NULL

Nature	NULL
Genet	NULL
.	NULL

1	NULL
;	NULL
92-98	NULL
.	NULL

Orkin	NULL
SH	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Globin	NULL
gene	NULL
regulation	NULL
and	NULL
switching	NULL
:	NULL
Circa	NULL
1990	NULL
.	NULL

Cell	NULL
63	NULL
:	NULL
665-672.	NULL
.	NULL

Philipsen	NULL
S	NULL
,	NULL
Talbot	NULL
D	NULL
,	NULL
Fraser	NULL
P	NULL
,	NULL
Grosveld	NULL
F.	NULL
(	NULL
1990	NULL
)	NULL
The	NULL
beta-globin	NULL
dominant	NULL
control	NULL
re-gion	NULL
:	NULL
Hypersensitive	NULL
site	NULL
2	NULL
.	NULL

EM.B.O	NULL
.	NULL

J	NULL
.	NULL

9	NULL
:	NULL
2159-2167	NULL
.	NULL

Fischer	NULL
KD	NULL
,	NULL
Haese	NULL
A	NULL
,	NULL
Nowock	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Cooperation	NULL
of	NULL
GATA-1	NULL
and	NULL
SP1	NULL
can	NULL
result	NULL
in	NULL
synergistic	NULL
transcriptional	NULL
activation	NULL
or	NULL
in-terference	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
:	NULL
23915-23923	NULL
.	NULL

Minie	NULL
ME	NULL
,	NULL
Kimura	NULL
T	NULL
,	NULL
Felsenfeld	NULL
G.	NULL
(	NULL
1992	NULL
)	NULL
The	NULL
developmental	NULL
switch	NULL
in	NULL
embryonic	NULL
rho-globin	NULL
expression	NULL
is	NULL
correlated	NULL
with	NULL
erythroid	NULL
lineage-specific	NULL
differences	NULL
in	NULL
transcription	NULL
factor	NULL
levels	NULL
.	NULL

Development	NULL
115	NULL
:	NULL
1149-1164	NULL
.	NULL

Orkin	NULL
SH	NULL
,	NULL
Harosi	NULL
FI	NULL
,	NULL
Leder	NULL
P.	NULL
(	NULL
1975	NULL
)	NULL
Differentiation	NULL
of	NULL
erythroleukemic	NULL
cells	NULL
and	NULL
their	NULL
somatic	NULL
hybrids	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
72	NULL
;	NULL
98-102	NULL
.	NULL

Schreiber	NULL
E	NULL
,	NULL
Matthias	NULL
P	NULL
,	NULL
Muller	NULL
MM	NULL
,	NULL
Schaffner	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Rapid	NULL
detection	NULL
of	NULL
oc-tamer	NULL
binding	NULL
proteins	NULL
with	NULL
'mini-extracts	NULL
'	NULL
prepared	NULL
from	NULL
a	NULL
small	NULL
number	NULL
of	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

15	NULL
:	NULL
6419-6436	NULL
.	NULL

Chomezynski	NULL
P	NULL
,	NULL
Sacchi	NULL
N.	NULL
(	NULL
1987	NULL
)	NULL
Single-step	NULL
method	NULL
of	NULL
RNA	NULL
isolation	NULL
by	NULL
acid	NULL
guani-dinium	NULL
thiocyanate-phenol-chloroform	NULL
extraction	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

162	NULL
:	NULL
156-159	NULL
.	NULL

Leonard	NULL
M	NULL
,	NULL
Brice	NULL
M	NULL
,	NULL
Engel	NULL
JD	NULL
,	NULL
Papayanno-	NULL
16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

E.	NULL
R.	NULL
Bacon	NULL
et	NULL
al	NULL
.	NULL

:	NULL
Transcription	NULL
Factors	NULL
in	NULL
Hemoglobin	NULL
Switching	NULL
305	NULL
poulou	NULL
T.	NULL
(	NULL
1993	NULL
)	NULL
Dynamics	NULL
of	NULL
GATA	NULL
transcription	NULL
factor	NULL
expression	NULL
during	NULL
erythroid	NULL
differentiation	NULL
.	NULL

Blood	NULL
82	NULL
:	NULL
1071-1079	NULL
.	NULL

Mantovani	NULL
R	NULL
,	NULL
Malgaretti	NULL
N	NULL
,	NULL
Nicolis	NULL
S	NULL
,	NULL
Ronchi	NULL
A	NULL
,	NULL
Giglioni	NULL
B	NULL
,	NULL
Ottolenghi	NULL
S.	NULL
(	NULL
1988	NULL
)	NULL
The	NULL
effects	NULL
of	NULL
HPFH	NULL
mutations	NULL
in	NULL
the	NULL
human	NULL
y-globin	NULL
promoter	NULL
on	NULL
binding	NULL
of	NULL
ubiquitous	NULL
and	NULL
erythroid	NULL
specific	NULL
nuclear	NULL
factors	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

16	NULL
;	NULL
7783-7797	NULL
.	NULL

Ronchi	NULL
A	NULL
,	NULL
Nicolis	NULL
S	NULL
,	NULL
Santoro	NULL
C	NULL
,	NULL
Ottolenghi	NULL
S.	NULL
(	NULL
1989	NULL
)	NULL
Increased	NULL
Spl	NULL
binding	NULL
mediates	NULL
ery-throid-specific	NULL
overexpression	NULL
of	NULL
a	NULL
mutated	NULL
(	NULL
HPFH	NULL
)	NULL
y-globin	NULL
promoter	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
:	NULL
10231-10240	NULL
.	NULL

Alter	NULL
BP	NULL
,	NULL
Coupal	NULL
E	NULL
,	NULL
Forget	NULL
BG	NULL
.	NULL

(	NULL
1981	NULL
)	NULL
Globin	NULL
chain	NULL
electrophoresis	NULL
for	NULL
prenatal	NULL
diagnosis	NULL
of	NULL
B-thalassemia	NULL
.	NULL

Hemoglobin	NULL
5	NULL
:	NULL
357-370	NULL
.	NULL

Tsai	NULL
FY	NULL
,	NULL
Keller	NULL
G	NULL
,	NULL
Kuo	NULL
FC	NULL
,	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
An	NULL
early	NULL
haematopoietic	NULL
defect	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
transcription	NULL
factor	NULL
GATA-2	NULL
.	NULL

Nature	NULL
371	NULL
:	NULL
221-226	NULL
.	NULL

Oppenheim	NULL
A	NULL
,	NULL
Yaari	NULL
A	NULL
,	NULL
Rund	NULL
D	NULL
,	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Intrinsic	NULL
potential	NULL
for	NULL
high	NULL
fetal	NULL
hemoglobin	NULL
production	NULL
in	NULL
a	NULL
Druz	NULL
family	NULL
with	NULL
beta-thalassemia	NULL
is	NULL
due	NULL
to	NULL
an	NULL
unlinked	NULL
genetic	NULL
determinant	NULL
.	NULL

Hum	NULL
.	NULL

Genet	NULL
.	NULL

86	NULL
:	NULL
175-180	NULL
.	NULL

Oppenheim	NULL
A	NULL
,	NULL
Katzir	NULL
Y	NULL
,	NULL
Fibach	NULL
E	NULL
,	NULL
Goldfarb	NULL
A	NULL
,	NULL
Rachmilewitz	NULL
EA	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Hypomethylation	NULL
of	NULL
DNA	NULL
derived	NULL
from	NULL
purified	NULL
human	NULL
erythroid	NULL
cells	NULL
correlates	NULL
with	NULL
gene	NULL
activity	NULL
of	NULL
the	NULL
beta-globin	NULL
cluster	NULL
.	NULL

Blood	NULL
66	NULL
:	NULL
1202-1207	NULL
.	NULL

Thein	NULL
SL	NULL
,	NULL
Sampietro	NULL
M	NULL
,	NULL
Rohde	NULL
K	NULL
,	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Detection	NULL
of	NULL
a	NULL
major	NULL
gene	NULL
for	NULL
hetero-cellular	NULL
hereditary	NULL
persistence	NULL
of	NULL
fetal	NULL
hemoglobin	NULL
after	NULL
accounting	NULL
for	NULL
genetic	NULL
modifiers	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Hum	NULL
.	NULL

Genet	NULL
.	NULL

54	NULL
:	NULL
214-228	NULL
.	NULL

Contributed	NULL
by	NULL
S.	NULL
H.	NULL
Orkin	NULL
on	NULL
January	NULL
3	NULL
,	NULL
1995	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

Platt	NULL
OS	NULL
,	NULL
Orkin	NULL
SH	NULL
,	NULL
Dover	NULL
G	NULL
,	NULL
Beardsly	NULL
GP	NULL
,	NULL
Miller	NULL
B	NULL
,	NULL
Nathan	NULL
DG	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Hydroxyurea	NULL
enhances	NULL
fetal	NULL
hemoglobin	NULL
production	NULL
in	NULL
sickle	NULL
cell	NULL
anemia	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

74	NULL
;	NULL
652-656	NULL
.	NULL

Perrine	NULL
SP	NULL
,	NULL
Gindr	NULL
GD	NULL
,	NULL
Faller	NULL
DV	NULL
,	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
A	NULL
short-term	NULL
trial	NULL
of	NULL
butyrate	NULL
to	NULL
stimulate	NULL
fetal-globin-gene	NULL
expression	NULL
in	NULL
the	NULL
B-globin	NULL
disorders	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

328	NULL
:	NULL
81-86	NULL
.	NULL

Fibach	NULL
E	NULL
,	NULL
Burke	NULL
LP	NULL
,	NULL
Schechter	NULL
LN	NULL
,	NULL
Noguchi	NULL
CT	NULL
,	NULL
Rodgers	NULL
GP	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Hydroxyurea	NULL
increases	NULL
fetal	NULL
hemoglobin	NULL
in	NULL
cultured	NULL
erythroid	NULL
cells	NULL
derived	NULL
from	NULL
normal	NULL
individuals	NULL
and	NULL
patients	NULL
with	NULL
sickle	NULL
cell	NULL
anemia	NULL
or	NULL
beta-thalassemia	NULL
.	NULL

Blood	NULL
81	NULL
:	NULL
1630-1635	NULL
.	NULL

Fibach	NULL
E	NULL
,	NULL
Prasanna	NULL
P	NULL
,	NULL
Rodgers	NULL
GP	NULL
,	NULL
Samid	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Enhanced	NULL
fetal	NULL
hemoglobin	NULL
production	NULL
by	NULL
phenylacetate	NULL
and	NULL
4-phenylbutyrate	NULL
in	NULL
erythroid	NULL
precursors	NULL
derived	NULL
from	NULL
normal	NULL
donors	NULL
and	NULL
patients	NULL
with	NULL
sickle	NULL
cell	NULL
anemia	NULL
and	NULL
beta-thalassemia	NULL
.	NULL

Blood	NULL
82	NULL
:	NULL
2203-2209	NULL
.	NULL

Grosveld	NULL
F	NULL
,	NULL
Blom	NULL
van	NULL
Assendelft	NULL
G	NULL
,	NULL
Greaves	NULL
DR	NULL
,	NULL
Kollias	NULL
G.	NULL
(	NULL
1987	NULL
)	NULL
Position-independenit	NULL
,	NULL
high-level	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
beta-globin	NULL
gene	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Cell	NULL
51	NULL
;	NULL
975-985	NULL
.	NULL

Forrester	NULL
WC	NULL
,	NULL
Epner	NULL
E	NULL
,	NULL
Driscoll	NULL
MC	NULL
,	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
A	NULL
deletion	NULL
of	NULL
the	NULL
human	NULL
beta-globin	NULL
locus	NULL
activation	NULL
region	NULL
causes	NULL
a	NULL
major	NULL
alteration	NULL
in	NULL
chromatin	NULL
structure	NULL
and	NULL
replication	NULL
across	NULL
the	NULL
entire	NULL
beta-globin	NULL
locus	NULL
.	NULL

Gene	NULL
.	NULL

Dev	NULL
.	NULL

4	NULL
:	NULL
1637-1649	NULL
.	NULL

Cao	NULL
SX	NULL
,	NULL
Gutman	NULL
PD	NULL
,	NULL
Dave	NULL
HP	NULL
,	NULL
Schechter	NULL
AN	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Identification	NULL
of	NULL
a	NULL
transcriptional	NULL
silencer	NULL
in	NULL
the	NULL
5	NULL
'	NULL
-flanking	NULL
region	NULL
of	NULL
the	NULL
human	NULL
epsilon-globin	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
86	NULL
:	NULL
5306-5309	NULL
.	NULL

